Trial Profile
Phase III Clinical Study of YP-18 in Intra-Abdominal Infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Intra-abdominal infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 27 May 2016 New trial record